B Cell-Directed Therapy May Delay RA Development in High-Risk Patients
RA Effectiveness Differs Among Non-TNF Inhibitors
Reminder: How to Handle Part D Prior Authorization Requests
FDA Approves Rituximab Biosimilar; Plus New Safety Data for Filgotinib in RA Patients
Annual Meeting Speakers Review Studies Ranging from Opioids to Fibroblasts
Long-Term Data Show Baricitinib Is Safe & Effective for RA
Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector
MUC5B Promoter Variant Associated with RA with Interstitial Lung Disease
Low Muscle Density & Physical Function in Patients with RA
- 1
- 2
- 3
- …
- 19
- Next Page »